When thinking about geographic diversity, many investors still instinctively look at where a company is headquartered. But in a globalised market, where a company earns its money is often far more important than where it is domiciled. Here are three ASX stocks to increase your global exposure.
Image source: Getty Images
Codan Ltd (ASX: CDA): A global earnings powerhouse
Codan is an Australian technology company with a reputation for durable communications and electronics equipment for the government, corporate, NGO and consumer markets. Its metal detector brand, Minelabs, is widely considered to be the industry standard for both commercial and private prospecting.
It operates in more than 150 countries globally, across North America, Africa, Europe and Asia, offering exposure to diverse markets.
Codan's share price hit all-time high in late January 2026, off the back of strong growth and revenue results in both its communications and metal detector divisions. It's metal detector business grew 46% in H1 FY26, largely driven by sales in Africa.
While we may see some of that growth slow if the price of gold continues to drop, its exposure to defence spending and reputation for quality should maintain momentum across its communications division.
In addition, the company has low debt and a disciplined approach, creating a fertile environment for long-term growth. In my opinion, Codan is a solid investment for long-term investors seeking geographic diversity, even at current prices.
Ramsay Health Care Ltd (ASX: RHC): A turnaround play in a resilient market
While Ramsay has a notable footprint in Australia, it's significant operations across Europe and the UK give it global revenue streams in the resilient healthcare market.
Here in Australia, Ramsay is the largest private hospital operator. In the UK, it provides similar services on a smaller scale alongside mental health services via its Elysium Healthcare subsidiary. Ramsay also holds a controlling stake in European-based Ramsay Santé, which delivers healthcare services across France, Sweden, Norway, Denmark and Italy.
In terms of performance, Ramsay is a turnaround play right now. Its share price has fallen around 45% across five years, potentially indicating that investors have lost confidence. That said, it is up circa 9% over the last year, and some analysts have suggested it is undervalued based on its strong fundamentals, margin recovery and Q1 FY2026 revenue growth.
It's an option worth exploring if you are looking to diversify and want a value play in a market with long-term growth tailwinds.
Cochlear Ltd (ASX: COH): Local success story with global reach
Cochlear is a primary example of an ASX-listed company with an extensive global footprint. This Australian invention is now a world leader in implantable hearing devices. And although it remains based in Sydney, it earns most of its revenue offshore.
Its most lucrative market is the Americas. This is followed by its Europe, Middle East and Africa and Asia Pacific operations, giving Cochlear diverse global revenue streams and fantastic earnings resilience.
In terms of share price, Cochlear has historically been a solid and dependable performer. In 2025, however, it saw some decline, starting the year at around $300 per share and ending it at around $260. While it continues to perform, investors may be losing patience with its relatively slow growth at such a high valuation.
If you're looking for an ASX stock with global revenue streams, Cochlear remains an excellent option. Given its continued success and solid long-term outlook, current share price declines may present an opportunity to buy.
